These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 31325479)
1. Skeletal muscle atrogenes: From rodent models to human pathologies. Taillandier D; Polge C Biochimie; 2019 Nov; 166():251-269. PubMed ID: 31325479 [TBL] [Abstract][Full Text] [Related]
2. FoxO-dependent atrogenes vary among catabolic conditions and play a key role in muscle atrophy induced by hindlimb suspension. Brocca L; Toniolo L; Reggiani C; Bottinelli R; Sandri M; Pellegrino MA J Physiol; 2017 Feb; 595(4):1143-1158. PubMed ID: 27767211 [TBL] [Abstract][Full Text] [Related]
3. Fbxw7β is an inducing mediator of dexamethasone-induced skeletal muscle atrophy in vivo with the axis of Fbxw7β-myogenin-atrogenes. Shin K; Ko YG; Jeong J; Kwon H Mol Biol Rep; 2018 Aug; 45(4):625-631. PubMed ID: 29671242 [TBL] [Abstract][Full Text] [Related]
4. Regulation of muscle atrophy-related genes by the opposing transcriptional activities of ZEB1/CtBP and FOXO3. Ninfali C; Siles L; Darling DS; Postigo A Nucleic Acids Res; 2018 Nov; 46(20):10697-10708. PubMed ID: 30304480 [TBL] [Abstract][Full Text] [Related]
5. Induction of ATF4-Regulated Atrogenes Is Uncoupled from Muscle Atrophy during Disuse in Halofuginone-Treated Mice and in Hibernating Brown Bears. Cussonneau L; Coudy-Gandilhon C; Deval C; Chaouki G; Djelloul-Mazouz M; Delorme Y; Hermet J; Gauquelin-Koch G; Polge C; Taillandier D; Averous J; Bruhat A; Jousse C; Papet I; Bertile F; Lefai E; Fafournoux P; Maurin AC; Combaret L Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614063 [TBL] [Abstract][Full Text] [Related]
6. Identification of potential target genes associated with the reversion of androgen-dependent skeletal muscle atrophy. de O Coelho P; Guarnier FA; Figueiredo LB; Zaramela LS; Pacini ESA; Godinho RO; Gomes MD Arch Biochem Biophys; 2019 Mar; 663():173-182. PubMed ID: 30639329 [TBL] [Abstract][Full Text] [Related]
7. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. Sacheck JM; Hyatt JP; Raffaello A; Jagoe RT; Roy RR; Edgerton VR; Lecker SH; Goldberg AL FASEB J; 2007 Jan; 21(1):140-55. PubMed ID: 17116744 [TBL] [Abstract][Full Text] [Related]
8. Dynamic changes in the mouse skeletal muscle proteome during denervation-induced atrophy. Lang F; Aravamudhan S; Nolte H; Türk C; Hölper S; Müller S; Günther S; Blaauw B; Braun T; Krüger M Dis Model Mech; 2017 Jul; 10(7):881-896. PubMed ID: 28546288 [TBL] [Abstract][Full Text] [Related]
9. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. Lecker SH; Jagoe RT; Gilbert A; Gomes M; Baracos V; Bailey J; Price SR; Mitch WE; Goldberg AL FASEB J; 2004 Jan; 18(1):39-51. PubMed ID: 14718385 [TBL] [Abstract][Full Text] [Related]
10. UBE2D2 is not involved in MuRF1-dependent muscle wasting during hindlimb suspension. Polge C; Koulmann N; Claustre A; Jarzaguet M; Serrurier B; Combaret L; Béchet D; Bigard X; Attaix D; Taillandier D Int J Biochem Cell Biol; 2016 Oct; 79():488-493. PubMed ID: 27378730 [TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase-4 inhibition reduces proteolysis and atrogenes expression in rat skeletal muscles. Lira EC; Gonçalves DA; Parreiras-E-Silva LT; Zanon NM; Kettelhut IC; Navegantes LC Muscle Nerve; 2011 Sep; 44(3):371-81. PubMed ID: 21996797 [TBL] [Abstract][Full Text] [Related]